A meaningful exploration of ofatumumab in refractory NMOSD: a case report.
Zhan Y, Zhao M, Li X, Ouyang H, Du C, Chen G, Lou Z, Chen H, Zhao Y, Xu H.
Zhan Y, et al. Among authors: zhao y, zhao m.
Front Immunol. 2023 Jun 28;14:1208017. doi: 10.3389/fimmu.2023.1208017. eCollection 2023.
Front Immunol. 2023.
PMID: 37449206
Free PMC article.